echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > Science Translational Medicine: instead of morphine to treat pain dependence! Gene therapy technology based on CRISPR and zinc finger protein relieves chronic pain

    Science Translational Medicine: instead of morphine to treat pain dependence! Gene therapy technology based on CRISPR and zinc finger protein relieves chronic pain

    • Last Update: 2021-03-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Chronic pain refers to pain that lasts more than one month.


    Studies have shown that voltage-gated sodium ion channels (Nav) are related to the occurrence of pain sensation, and Nav1.


    On March 10, 2021, the University of California, San Diego, published a study titled "Long-lasting analgesia via targeted in situ repression of NaV1.


    In order to develop a long-lasting and non-addictive product that relieves chronic pain, the researchers explored two independent genetic methods to inhibit the spread of pain at the spine level.


    Schematic diagram of the genetics of inhibiting chronic pain in mice

    Schematic diagram of the genetics of inhibiting chronic pain in mice Schematic diagram of the genetics of inhibiting chronic pain in mice

    Next, the researchers explored the performance of two methods of inhibiting NaV1.


    The first is the carrageenan-induced inflammatory pain model.


    Related expressions of NaV1.


    Related expression of NaV1.


    Tactile allodynia threshold in mice after administration of paclitaxel

    Tactile allodynia threshold in mice after paclitaxel administration.


    Tactile allodynia threshold in mice after injection of BzATP

    Tactile allodynia threshold in mice after BzATP injection The tactile allodynia threshold in mice after BzATP injection

    To further determine whether NaV1.


    Repeat PWL of carrageenan model mice on day 42, 84 and 308

    Repeat PWL of carrageenan model mice on day 42, 84 and 308

    The researchers measured the allodynia threshold in mice 105 days after the AAV injection and 85 days after the last paclitaxel injection.


    Pain threshold of mice 85 days after injection of paclitaxel

    The pain threshold of mice 85 days after paclitaxel injection The pain threshold of mice 85 days after paclitaxel injection

    Finally, in order to determine the potential side effects of inhibiting NaV1.


    In general, this therapy knocked down the expression of Nav1.


    Original source:

    Original source:

    Ana M.


    sciencemag.
    org/content/13/584/eaay9056" target="_blank" rel="noopener">Long-lasting analgesia via targeted in situ repression of NaV1.
    7 in mice.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.